A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
To access this article, please choose from the options below
PII: S1368-8375(01)00134-8
© 2002 Elsevier Science Ltd. All rights reserved.
PII: S1368-8375(01)00134-8
© 2002 Elsevier Science Ltd. All rights reserved.